Technology
Health
Biotechnology

India Globalization Capital

$1.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (4.95%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell IGC and other stocks, options, ETFs, and crypto commission-free!

About IGC

India Globalization Capital, Inc. engages in the development and commercialization of cannabinoid based alternative therapies for indications such as Alzheimer's disease, Parkinson's disease, and pain. It operates through the Infrastructure Business and Plant & Cannabinoids Business segments. Read More The Infrastructure Business segment involves the rental of heavy construction equipment, execution of construction contracts, and purchase and reseal of physical commodities used in infrastructure. The Plant & Cannabinoids Business segment comprises the production of plant and cannabinoid-based products, and therapies. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Employees
20
Headquarters
Potomac, Maryland
Founded
2005
Market Cap
41.88M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
307.63K
High Today
$1.11
Low Today
$1.01
Open Price
$1.02
Volume
284.06K
52 Week High
$14.58
52 Week Low
$0.38

Collections

Technology
Health
Biotechnology
Construction
US
North America
Asia (Non-China)
Asia

IGC Earnings

-$0.06
-$0.05
-$0.03
-$0.02
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
Actual
-$0.03 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.